June 28th 2023
GLP-1 receptor agonists supply notice
Intermittent supply until at least mid-2024
DHSC has issued a tier 3 medicine supply notification for GLP-1 receptor agonists used in the management of type 2 diabetes.
The MSN advises that there are very limited, intermittent supplies of all gluca